Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Safety Review For Upset Stomach, Hangover OTCs Reconsiders Science

Executive Summary

The US Nonprescription Drugs and Drug Safety and Risk Management advisory committees will discuss the safety of using OTC analgesic combination products for upset stomach and hangover even though Drug Facts labels already warn about the risk of serious bleeding.

Advertisement

Related Content

What’s Next For Antacid/Analgesic OTCs After Negative US FDA Panel?
What’s Next For Antacid/Analgesic OTCs After Negative US FDA Panel?
US FDA Serves One Antacid/Analgesic Question For AdComm, Opens Tap On Hangover Discussion
US FDA Serves One Antacid/Analgesic Question For AdComm, Opens Tap On Hangover Discussion
Alka-Seltzer Antacid Will 'Plop, Plop Fizz, Fizz' Without Aspirin
Alka-Seltzer Antacid Will 'Plop, Plop Fizz, Fizz' Without Aspirin
OTC Hangover Remedy Safety On Tap For FDA Advisory Committees
OTC Antacid/Aspirin Bleeding Risk Raises Concerns At CDER
“No End In Sight” For Completing OTC Monographs – CDER Director Woodcock

Topics

Advertisement
UsernamePublicRestriction

Register

PS120169

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel